Vaccine Technologies Market to Reach $90.6 billion, Globally, by 2033 at 6.4% CAGR: Allied Market Research
February 10, 2025 09:31 ET
|
Allied Market Research INC
Wilmington, Delaware, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Technologies Market by Technology (Live Attenuated Vaccines, Inactivated Vaccines,...
Viral Vaccines Market Size is Projected to Reach USD 93.42 Billion by 2033, Growing at a CAGR of 8.4%: Straits Research
February 03, 2025 09:19 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Viruses including influenza, mumps, measles, and hepatitis can be among the world's deadliest killers. Researchers from all around the...
Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19
January 27, 2025 06:30 ET
|
Ocugen
OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clinical trial is anticipated to start in 2Q...
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
January 12, 2025 10:00 ET
|
Curevo Vaccine
Updated Phase 2 data one year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix
Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 11:30 ET
|
Curevo Vaccine
Curevo Vaccine will present at the 2025 JPM Healthcare Conference on Wednesday January 15th.
CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
December 10, 2024 06:00 ET
|
Accumulus Synergy
OSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health...
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
November 21, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates...
Pacific Genetech Hercules Delivery System Recognized With “Vaccine Innovation Of The Year” By BioTech Breakthrough
November 19, 2024 08:01 ET
|
BioTech Breakthrough
FAYETTEVILLE, Ark., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Pacific Genetech today announced that Hercules is the recipient of the “Vaccine Innovation Of The Year” award in the fourth annual BioTech...
Global Veterinary Vaccine Adjuvants Market to Reach USD 674.2 Million by 2034, Driven by Rising Demand for Animal Health Solutions | FMI
November 18, 2024 11:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The global veterinary vaccine adjuvants market is experiencing strong growth, with sales estimated to reach USD 431.4 million in 2024 and projected to...
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
November 12, 2024 08:00 ET
|
Evaxion Biotech
New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the successful design of a proprietary...